Norgestimate

This classification denotes a therapeutic progestin with the molecular formula C23H31NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C291HFX4DY, chemically known as 18,19-dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (17-alpha)- but generally known as norgestimate, which bears US NIH Compound Identifier 6540478. European Medicines Agency schedules Norgestimate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09369MIG. The term NORGESTIMATE is an International Non-Proprietary Name. NORGESTIMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule norgestimate under HS 29372300 and SITC 54153. As of Q4 2014, NORGESTIMATE remains the US FDA Preferred Term for this commodity. Norgestimate bears US NLM identifiers UMLS ID C0068992 and NCI Concept Code C66245. SMILES: O(C1(C2(C(C3C(CC2)C2C(=CC(=N\O)\CC2)CC3)CC1)CC)C#C)C(=O)C.